These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18513234)

  • 1. The Bcl-2 antagonist HA14-1 forms a fluorescent albumin complex that can be mistaken for several oxidized ROS probes.
    Kessel D; Price M; Reiners JJ
    Photochem Photobiol; 2008; 84(5):1272-6. PubMed ID: 18513234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic response to photodynamic therapy versus the Bcl-2 antagonist HA14-1.
    Kessel D; Castelli M; Reiners JJ
    Photochem Photobiol; 2002 Sep; 76(3):314-9. PubMed ID: 12403453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.
    Rehman K; Tariq M; Akash MS; Gillani Z; Qazi MH
    Chem Biol Drug Des; 2014 Mar; 83(3):317-23. PubMed ID: 24118733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism.
    Pei XY; Dai Y; Grant S
    Mol Cancer Ther; 2004 Dec; 3(12):1513-24. PubMed ID: 15634644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical upstream signals of cytochrome C release induced by a novel Bcl-2 inhibitor.
    An J; Chen Y; Huang Z
    J Biol Chem; 2004 Apr; 279(18):19133-40. PubMed ID: 14966123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195.
    Chen J; Freeman A; Liu J; Dai Q; Lee RM
    Mol Cancer Ther; 2002 Oct; 1(12):961-7. PubMed ID: 12481420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death.
    Manero F; Gautier F; Gallenne T; Cauquil N; Grée D; Cartron PF; Geneste O; Grée R; Vallette FM; Juin P
    Cancer Res; 2006 Mar; 66(5):2757-64. PubMed ID: 16510597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of PDT efficacy by a Bcl-2 antagonist.
    Kessel D
    Photochem Photobiol; 2008; 84(3):809-14. PubMed ID: 18179619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis.
    Doshi JM; Tian D; Xing C
    Mol Pharm; 2007; 4(6):919-28. PubMed ID: 17874842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of HA14-1 mediated oxidative stress, toxic response, and autophagy by curcumin to enhance apoptotic activity in human embryonic kidney cells.
    Ranjan K; Sharma A; Surolia A; Pathak C
    Biofactors; 2014; 40(1):157-69. PubMed ID: 23559532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
    Hao JH; Yu M; Liu FT; Newland AC; Jia L
    Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells.
    Sinicrope FA; Penington RC; Tang XM
    Clin Cancer Res; 2004 Dec; 10(24):8284-92. PubMed ID: 15623604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide response post-photodamage is absent after treatment with HA14-1.
    Separovic D; Wang S; Awad Maitah MY; Hanada K; Kessel D
    Biochem Biophys Res Commun; 2006 Jun; 345(2):803-8. PubMed ID: 16701558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric analysis of HA14-1-induced apoptosis in follicular lymphoma cells.
    Wlodkowic D; Skommer J; Pelkonen J
    Leuk Res; 2006 Sep; 30(9):1187-92. PubMed ID: 16414117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.
    Lickliter JD; Wood NJ; Johnson L; McHugh G; Tan J; Wood F; Cox J; Wickham NW
    Leukemia; 2003 Nov; 17(11):2074-80. PubMed ID: 12931228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
    Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J
    Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.
    Simonin K; Brotin E; Dufort S; Dutoit S; Goux D; N'diaye M; Denoyelle C; Gauduchon P; Poulain L
    Mol Cancer Ther; 2009 Nov; 8(11):3162-70. PubMed ID: 19887550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective Bcl-2 inhibitor HA14-1 treatments on functional activity of magnocellular vasopressinergic neurons of rat hypothalamus.
    Chernigovskaya EV; Nikitina LS; Dorofeeva NA; Glazova MV
    Neurosci Lett; 2008 May; 437(1):59-64. PubMed ID: 18434013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct mechanisms of neuronal apoptosis are triggered by antagonism of Bcl-2/Bcl-x(L) versus induction of the BH3-only protein Bim.
    Zimmermann AK; Loucks FA; Le SS; Butts BD; Florez-McClure ML; Bouchard RJ; Heidenreich KA; Linseman DA
    J Neurochem; 2005 Jul; 94(1):22-36. PubMed ID: 15953346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.